{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:15:06Z","timestamp":1793218506164,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,5,25]],"date-time":"2014-05-25T00:00:00Z","timestamp":1400976000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00520-014-2285-1","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T21:17:08Z","timestamp":1400879828000},"page":"2271-2280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":137,"title":["Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"22","author":[{"given":"Heather L.","family":"McGinty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin M.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather S. L.","family":"Jim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Cessna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Asvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory G.","family":"Cases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent J.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,25]]},"reference":[{"key":"2285_CR1","unstructured":"National Comprehensive Cancer Network (2013) NCCN clinical practice guidelines in oncology version 2: 2013 Prostate cancer information. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf . Accessed 01 June 2013"},{"key":"2285_CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.critrevonc.2006.06.006","volume":"60","author":"SMH Alibhai","year":"2006","unstructured":"Alibhai SMH, Gogov S, Allibhai Z (2006) Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 60:201\u2013215. doi: 10.1016\/j.critrevonc.2006.06.006","journal-title":"Crit Rev Oncol Hematol"},{"key":"2285_CR3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1349-7006.2010.01774.x","volume":"102","author":"H Akaza","year":"2011","unstructured":"Akaza H (2011) Combined androgen blockade for prostate cancer: review of efficacy, safety and cost-effectiveness. Cancer Sci 102:51\u201356. doi: 10.1111\/j.1349-7006.2010.01774.x","journal-title":"Cancer Sci"},{"key":"2285_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11934-005-0010-9","volume":"6","author":"R Kumar","year":"2005","unstructured":"Kumar R, Barqawi A, Crawford ED (2005) Preventing and treating the complications of hormone therapy. Curr Urol Rep 6:217\u2013223. doi: 10.1007\/s11934-005-0010-9","journal-title":"Curr Urol Rep"},{"key":"2285_CR5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.maturitas.2011.05.012","volume":"69","author":"J Holland","year":"2011","unstructured":"Holland J, Bandelow S, Hogervorst E (2011) Testosterone levels and cognition in elderly men: a review. Maturitas 69:322\u2013337. doi: 10.1016\/j.maturitas.2011.05.012","journal-title":"Maturitas"},{"key":"2285_CR6","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1210\/jc.2002-020419","volume":"87","author":"SD Moffat","year":"2002","unstructured":"Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM (2002) Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 87:5001\u20135007. doi: 10.1210\/jc.2002-020419","journal-title":"J Clin Endocrinol Metab"},{"key":"2285_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.psyneuen.2005.12.005","volume":"31","author":"PP Thilers","year":"2006","unstructured":"Thilers PP, MacDonald SWS, Herlitz A (2006) The association between endogenous free testosterone and cognitive performance: a population-based study in 35 to 90\u00a0year-old men and women. Psychoneuroendocrinology 31:565\u2013576. doi: 10.1016\/j.psyneuen.2005.12.005","journal-title":"Psychoneuroendocrinology"},{"key":"2285_CR8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2307\/1130467","volume":"56","author":"MC Linn","year":"1985","unstructured":"Linn MC, Petersen AC (1985) Emergence and characterization of sex differences in spatial ability: a meta-analysis. Child Dev 56:1479\u20131498. doi: 10.2307\/1130467","journal-title":"Child Dev"},{"key":"2285_CR9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1037\/0033-2909.117.2.250","volume":"117","author":"D Voyer","year":"1995","unstructured":"Voyer D, Voyer S, Bryden MP (1995) Magnitude of sex differences in spatial abilities: a meta-analysis and consideration of critical variables. Psychol Bull 117:250\u2013270. doi: 10.1037\/0033-2909.117.2.250","journal-title":"Psychol Bull"},{"key":"2285_CR10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/cncr.23658","volume":"113","author":"CJ Nelson","year":"2008","unstructured":"Nelson CJ, Lee JS, Gamboa MC, Roth AJ (2008) Cognitive effects of hormone therapy in men with prostate cancer. Cancer 113:1097\u20131106. doi: 10.1002\/cncr.23658","journal-title":"Cancer"},{"key":"2285_CR11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/aja.2011.107","volume":"14","author":"RJ Jamadar","year":"2012","unstructured":"Jamadar RJ, Winters MJ, Maki PM (2012) Cognitive changes associated with ADT: a review of the literature. Asian J Androl 14:232\u2013238. doi: 10.1038\/aja.2011.107","journal-title":"Asian J Androl"},{"key":"2285_CR12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264\u2013269. doi: 10.1371\/journal.pmed.1000097","journal-title":"Ann Intern Med"},{"key":"2285_CR13","volume-title":"Neuropsychological assessment","author":"MD Lezak","year":"2004","unstructured":"Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment, 4th edn. Oxford University Press, New York","edition":"4"},{"key":"2285_CR14","volume-title":"Statistical methods for meta-analysis","author":"LV Hedges","year":"1985","unstructured":"Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic Press, San Diego"},{"key":"2285_CR15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188. doi: 10.1016\/0197-2456(86)90046-2","journal-title":"Control Clin Trials"},{"key":"2285_CR16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2307\/1164923","volume":"8","author":"RG Orwin","year":"1983","unstructured":"Orwin RG (1983) A fail-safe N for effect size in meta-analysis. J Educ Stat 8:157\u2013159","journal-title":"J Educ Stat"},{"key":"2285_CR17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.bjc.6601235","volume":"89","author":"E Salminen","year":"2003","unstructured":"Salminen E, Portin R, Korpela J, Backman H, Parvinen L-M, Helenius H, Nurmi M (2003) Androgen deprivation and cognition in prostate cancer. Br J Cancer 89:971\u2013976. doi: 10.1038\/sj.bjc.6601235","journal-title":"Br J Cancer"},{"key":"2285_CR18","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1200\/JCO.2010.30.8742","volume":"28","author":"SMH Alibhai","year":"2010","unstructured":"Alibhai SMH, Breunis H, Timilshina N, Marzouk S, Stewart D, Tannock I, Naglie G et al (2010) Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. J Clin Oncol 28:5030\u20135037. doi: 10.1200\/JCO.2010.30.8742","journal-title":"J Clin Oncol"},{"key":"2285_CR19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1464-410X.2002.02917.x","volume":"90","author":"HJ Green","year":"2002","unstructured":"Green HJ, Pakenham KI, Headley BC, Yaxley J, Nicol DL, MacTaggart PN, Swanson CE et al (2002) Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int 90:427\u2013432. doi: 10.1046\/j.1464-4096.2002.02917.x","journal-title":"BJU Int"},{"key":"2285_CR20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1464-410X.2004.04763.x","volume":"93","author":"HJ Green","year":"2004","unstructured":"Green HJ, Pakenham KI, Headley BC, Yaxley J, Nicol DL, MacTaggart PN, Swanson CE et al (2004) Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU Int 93:975\u2013979. doi: 10.1111\/j.1464-410X.2004.04763.x","journal-title":"BJU Int"},{"key":"2285_CR21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.psyneuen.2009.06.012","volume":"35","author":"RH Matousek","year":"2010","unstructured":"Matousek RH, Sherwin BB (2010) A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog. Psychoneuroendocrinology 35:215\u2013225. doi: 10.1016\/j.psyneuen.2009.06.012","journal-title":"Psychoneuroendocrinology"},{"key":"2285_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-10-1","volume":"10","author":"MM Cherrier","year":"2010","unstructured":"Cherrier MM, Borghesani PR, Shelton AL, Higano CS (2010) Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study. BMC Cancer 10:1\u20138. doi: 10.1186\/1471-2407-10-1","journal-title":"BMC Cancer"},{"key":"2285_CR23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1037\/0735-7044.119.6.1429","volume":"119","author":"JR Bussiere","year":"2005","unstructured":"Bussiere JR, Beer TM, Neiss MB, Janowsky JS (2005) Androgen deprivation impairs memory in older men. Behav Neurosci 119:1429\u20131437. doi: 10.1037\/0735-7044.119.6.1429","journal-title":"Behav Neurosci"},{"key":"2285_CR24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2522\/ptj.20060302","volume":"87","author":"CA Clay","year":"2007","unstructured":"Clay CA, Perera S, Wagner JM, Miller ME, Nelson JB, Greenspan SL (2007) Physical function in men with prostate cancer on androgen deprivation therapy. Phys Ther 87:1325\u20131333. doi: 10.2522\/ptj.20060302","journal-title":"Phys Ther"},{"key":"2285_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00520-009-0625-3","volume":"18","author":"HSL Jim","year":"2010","unstructured":"Jim HSL, Small BJ, Patterson S, Salup R, Jacobsen PB (2010) Cognitive impairment in men treated with luteinizing hormone-releasing hormone agonists for prostate cancer: a controlled comparison. Support Care Cancer 18:21\u201327. doi: 10.1007\/s00520-009-0625-3","journal-title":"Support Care Cancer"},{"key":"2285_CR26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.psyneuen.2003.11.002","volume":"29","author":"OP Almeida","year":"2004","unstructured":"Almeida OP, Waterreus A, Spry N, Flicker L, Martins RN (2004) One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 29:1071\u20131081. doi: 10.1016\/j.psyneuen.2003.11.002","journal-title":"Psychoneuroendocrinology"},{"key":"2285_CR27","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1097\/01.ju.0000091640.59812.83","volume":"170","author":"MM Cherrier","year":"2003","unstructured":"Cherrier MM, Rose AL, Higano C (2003) The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol 170:1808\u20131811. doi: 10.1097\/01.ju.0000091640.59812.83","journal-title":"J Urol"},{"key":"2285_CR28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/pon.1401","volume":"18","author":"MM Cherrier","year":"2009","unstructured":"Cherrier MM, Aubin S, Higano CS (2009) Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer. Psychooncology 18:237\u2013247. doi: 10.1002\/pon.1401","journal-title":"Psychooncology"},{"key":"2285_CR29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1464-410X.2005.05565.x","volume":"96","author":"VA Jenkins","year":"2005","unstructured":"Jenkins VA, Bloomfield DJ, Shilling VM, Edington TL (2005) Does neoadjuvant hormone therapy for early prostate cancer affect cognition? results from a pilot study. BJU Int 96:48\u201353. doi: 10.1111\/j.1464-410X.2005.05565.x","journal-title":"BJU Int"},{"key":"2285_CR30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jgo.2010.03.001","volume":"1","author":"SG Mohile","year":"2010","unstructured":"Mohile SG, Lacy M, Rodin M, Bylow K, Dale W, Meager MR, Stradler WM (2010) Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer. J Geriatr Oncol 1:13\u201319. doi: 10.1016\/j.critrevonc.2010.06.009","journal-title":"J Geriatr Oncol"},{"key":"2285_CR31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/pcan.2008.51","volume":"12","author":"DA Galvao","year":"2008","unstructured":"Galvao DA, Joseph D, Spry N, Joseph D, Turner D, Newton RU (2008) Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation. Prostate Cancer Prostatic Dis 12:198\u2013203. doi: 10.1038\/pcan.2008.51","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2285_CR32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","volume":"87","author":"MR Smith","year":"2002","unstructured":"Smith MR, Finkelstein JS, McGovern FJ, Zeitman AL, Fallon MA, Schoenfeld DA, Kantoff PW (2002) Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 87:599\u2013603","journal-title":"J Clin Endocrinol Metab"},{"key":"2285_CR33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.urology.2003.10.063","volume":"63","author":"MR Smith","year":"2004","unstructured":"Smith MR (2004) Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology 63:742\u2013745. doi: 10.1016\/j.urology.2003.10.063","journal-title":"Urology"},{"key":"2285_CR34","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.urology.2008.03.032","volume":"72","author":"K Bylow","year":"2008","unstructured":"Bylow K, Dale W, Mustian K, Stadler WM, Rodin M, Hall W, Lachs M et al (2008) Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy. Urology 72:422\u2013427. doi: 10.1016\/j.urology.2008.03.032","journal-title":"Urology"},{"key":"2285_CR35","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1017\/S1355617703970019","volume":"9","author":"CAY Anderson-Hanley","year":"2003","unstructured":"Anderson-Hanley CAY, Sherman ML, Riggs R, Agocha VB, Compas BE (2003) Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 9:967\u2013982. doi: 10.1017\/S1355617703970019","journal-title":"J Int Neuropsychol Soc"},{"key":"2285_CR36","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.21469","volume":"104","author":"CE Jansen","year":"2005","unstructured":"Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J (2005) A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104:2222\u20132233. doi: 10.1002\/cncr.21469","journal-title":"Cancer"},{"key":"2285_CR37","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1200\/JCO.2011.39.5640","volume":"30","author":"HSL Jim","year":"2012","unstructured":"Jim HSL, Phillips KM, Chait S, Faul LA, Popa MA, Lee Y-M, Hussin MG et al (2012) Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 30:3578\u20133587. doi: 10.1200\/JCO.2011.39.5640","journal-title":"J Clin Oncol"},{"key":"2285_CR38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-007-9686-5","volume":"110","author":"TA Ahles","year":"2008","unstructured":"Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Hanscom BS, Mulrooney TJ et al (2008) Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 110:143\u2013152. doi: 10.1007\/s10549-007-9686-5","journal-title":"Breast Cancer Res Treat"},{"key":"2285_CR39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/13803390903032537","volume":"32","author":"B Cimprich","year":"2010","unstructured":"Cimprich B, Reuter-Lorenz P, Nelson J, Clark PM, Therrien B, Normolle D, Berman MG et al (2010) Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 32:324\u2013331. doi: 10.1080\/13803390903032537","journal-title":"J Clin Exp Neuropsychol"},{"key":"2285_CR40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0169-5002(95)00446-8","volume":"12","author":"CA Meyers","year":"1995","unstructured":"Meyers CA, Byrne KS, Komaki R (1995) Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 12:231\u2013235","journal-title":"Lung Cancer"},{"key":"2285_CR41","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1200\/JCO.2006.07.8303","volume":"24","author":"SB Schagen","year":"2006","unstructured":"Schagen SB, van Dam FSAM (2006) Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect? J Clin Oncol 24:5170\u20135171. doi: 10.1200\/JCO.2006.07.8303","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2285-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-014-2285-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2285-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T18:56:19Z","timestamp":1565463379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-014-2285-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,25]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2285"],"URL":"https:\/\/doi.org\/10.1007\/s00520-014-2285-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,25]]}}}